AnilAnanthaneniMD

PubMed

• 28 citations
  Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?
  Anil A. Kumar, Ayesha De Costa, Arundathi Das, G A Srinivasa, George D'Souza
  JMIR Mhealth and Uhealth. 2019-04-03
• 2 citations
  Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study.
  Rashmi Rodrigues, Suman Sarah Varghese, Mohammed Mahrous, Anil Ananthaneni Kumar, Mohammed Naseer Ahmed
  BMJ Open. 2023-05-29
• 11 citations
  Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study.
  Zaki Al-Yafeai, Mohamed Ghoweba, Anil Ananthaneni, Hamzah Abduljabar, David Aziz
  British Journal of Clinical Pharmacology. 2023-02-01

Abstracts/Posters

• Variant of Unknown Significance in the EGLN-1 Gene Associated With Familial Erythrocytosis
  Kirsten Maddox, Anil Ananthaneni, Jamie Lee Aldakkour, Poornima Ramadas, SOHO 2024, Houston, Texas, 9/2024
• Immunosuppressant drug-associated skin cancer: A real-world pharmacovigilance database analysis
  Anil Ananthaneni, Sarah Jones, Daniyal Nadeem, Sydney Moore, Mohamed Ghoweba, Poornima Ramadas, 2024 ASCO Annual Meeting, Chicago, IL, 5/29/2024
• Immunosuppressant Drug-Associated Non-Hodgkin Lymphoma: A Real-World Pharmacovigilance Database Analysis
  Anil Ananthaneni, David Heap, Francesca Weis, Sriram Chowdary, Riya Sam, Zaki Al-Yafeai, Poornima Ramadas, 65th ASH Annual Meeting & Exposition, San Diego, CA, 11/28/2023
• Are We Diagnosing and Managing Diabetes in Patients with Sickle Cell Disorders Accurately?
  Anil Ananthaneni, Nakoma Walker, Rahul Vyas, Francesca Weis, David Heap, Sriram Chowdary, Nishith Alva, Sara Abdelaziz, Poornima Ramadas, 65th ASH Annual Meeting & Exposition, San Diego, CA, 11/28/2023
• Real-world analysis of cardiac, gastrointestinal, and hematologic toxicities between commonly used antiemetics in everyday oncology clinical practice.
  Kavitha Beedupalli, Anil Ananthaneni, Dawood Findakly, 2023 ASCO Annual Meeting, Chicago, IL, 5/31/2023
• Bortezomib-induced cardiotoxicity: Real-world data from a single-center.
  Suma Sri Chennapragada, Anil Ananthaneni, Shivani Sharma, Sindhu Priya Devarashetty, Runhua Shi, Poornima Ramadas, 2023 ASCO Annual Meeting, Chicago, IL, 5/31/2023
• Outcomes in Pregnant HbSS and HbSβ0-Thalassemia Sickle Cell Disease Patients Receiving Scheduled Exchange Transfusions: A Retrospective Study
  Anil Ananthaneni, Taras Benzar, Vishwa Grant, Kenna Leethy, Jacqueline Walton, Samip R Master, Richard Preston Mansour, Poornima Ramadas, 64th ASH Annual Meeting & Exposition, New Orleans, LA, 11/15/2022
• Comparison of Adverse Event Profiles of Rituximab, Rituximab Hycela and Rituximab Biosimilars: A Real-World Pharmacovigilance Database Analysis
  Dinesh Keerty, Anil Ananthaneni, Poornima Ramadas, Samip R Master, 64th ASH Annual Meeting & Exposition, New Orleans, LA, 11/15/2022
• ADAMTS13 Overtesting in Hospitalized Patients with Suspected TTP: A Retrospective Study
  Anil Ananthaneni, Udhayvir Singh Grewal, Tyiesha Sharron Brown, Zaki Al-Yafeai, Samip R. Master, Kavitha Beedupalli, 64th ASH Annual Meeting & Exposition, New Orleans, LA, 11/15/2022
• AML-336 De Novo M5b AML With t(8;16) (p11.2; p13.3) KAT6A/CREBBP Fusion and FLT3-TKD Mutation: Analysis of Mitelman Database
  Anil Ananthaneni, Taras Benzar, Fatima Iqbal, Hugo Akabane, Society of Hematologic Oncology - 10th Annual Meeting, Houston, TX, 10/1/2022
• Join now to see all